Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.
about
Molecular mechanisms underlying the antitumor activity of (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide in human colorectal cancer cells in vitro and in vivo.M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.
P2860
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@ast
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@en
type
label
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@ast
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@en
prefLabel
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@ast
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@en
P2093
P2860
P356
P1433
P1476
Novel oral histone deacetylase ...... lymphoma in vitro and in vivo.
@en
P2093
Che-Ming Teng
Chieh-Yu Peng
Chun-Han Chen
Han-Li Huang
Hsueh-Yun Lee
Jing-Chi Wang
Jing-Ping Liou
Mei-Jung Lai
Shiow-Lin Pan
P2860
P304
P356
10.18632/ONCOTARGET.3213
P407
P577
2015-03-01T00:00:00Z